Ourofino Saúde Animal

Ourofino Saúde Animal is a leading Brazilian company specializing in the research, development, and manufacturing of veterinary medicines. The company operates a large-scale, modern industrial complex in Cravinhos, São Paulo, which is one of the most advanced in Latin America. Its diverse product portfolio caters to both production animals, such as cattle and swine, and companion animals like dogs and cats. Key product categories include parasiticides, vaccines, antibiotics, and reproductive hormones designed to improve animal welfare and productivity. Ourofino maintains a strong focus on innovation and sustainability, leveraging a robust R&D department to bring new therapeutic solutions to the market. In 2024, the company transitioned from a public entity to a private one following an acquisition by Mitsui & Co. and Mubadala Capital.